FCM
LLY icon

Farallon Capital Management’s Eli Lilly LLY Stock Holding History

Farallon Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-375,000
Closed -$403M – 190
2025
Q4 		$403M Hold
375,000
– – 1.83% 19
2025
Q3 		$286M Buy
+375,000
New +$279M 1.17% 29

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Farallon Capital Management's LLY Position: Q2 2017 in Review

Farallon Capital Management sold out of Eli Lilly (LLY) in Q2 2017, closing a stake of 1,597,500 shares — an estimated $134M sold.

Farallon Capital Management first reported a position in LLY in Q4 2016 and held it in 2 quarters. The position peaked at $134M in Q1 2017. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • Farallon Capital Management reported no remaining Eli Lilly position as of Q2 2017 after selling out during the quarter.
  • Farallon Capital Management sold 1,597,500 Eli Lilly shares in Q2 2017, an estimated $134M.
  • Farallon Capital Management first reported a position in Eli Lilly in Q4 2016 and held it in 2 quarters.
  • Farallon Capital Management's Eli Lilly position peaked at $134M in Q1 2017.
  • 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on Farallon Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.